izokibep (ABY-035) / ACELYRIN 
Welcome,         Profile    Billing    Logout  
 0 Diseases   0 Trials   0 Trials   5 News 
7 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
izokibep (ABY-035) / ACELYRIN
NCT05905783: Hidradenitis Suppurativa Study of Izokibep

Active, not recruiting
3
258
Europe, Canada, Japan, US
Placebo, Izokibep
ACELYRIN Inc.
Hidradenitis Suppurativa
07/24
05/25
NCT05623345: Psoriatic Arthritis Study of Izokibep

Terminated
2/3
351
Europe, Canada, US, RoW
Izokibep, Placebo to izokibep
ACELYRIN Inc.
Psoriatic Arthritis
11/23
10/24
2020-004964-25: Multinational, multicenter, phase 2 study of the efficacy and safety of ABY-035 in treating and preventing relapse/recurrence of disease activity in subjects with non-infectious intermediate, posterior or pan-uveitis.

Not yet recruiting
2
110
Europe
ABY-035, Decortin H, ABY-035, Solution for injection, Decortin H
Affibody AB, Affibody AB
non-infectious intermediate, posterior, or pan-uveitis, non-infectious intermediate, posterior, or pan-uveitis, Diseases [C] - Eye Diseases [C11]
 
 
2021-005713-13: A Study to Evaluate the Efficacy and Safety of Izokibep in Subjects with Moderate to Severe Hidradenitis Suppurativa

Not yet recruiting
2
206
Europe
Izokibep, ABY-035, Solution for injection
ACELYRIN, INC., ACELYRIN, Inc., ACELYRIN, INC., ACELYRIN, Inc.
Hidradenitis Suppurativa, Hidradenitis Suppurativa, Diseases [C] - Skin and Connective Tissue Diseases [C17]
 
 
2021-006498-49: Study of Izokibep in Non-infectious, Intermediate-, Posterior- orPan-uveitis

Not yet recruiting
2
120
Europe
Izokibep, ABY-035, Solution for injection
ACELYRIN, Inc., ACELYRIN, INC., ACELYRIN, Inc., ACELYRIN, INC., Acelyrin, Inc.
Non-infectious, Intermediate-, Posterior- or Pan-uveitis, uveitis, Diseases [C] - Eye Diseases [C11]
 
 
NCT05355805: Hidradenitis Suppurativa Phase 2b Study of Izokibep

Completed
2
205
Europe, Canada, US
Izokibep, Placebo to izokibep
ACELYRIN Inc.
Hidradenitis Suppurativa
08/23
02/24
NCT05384249: Phase 2b Pivotal Study of Izokibep in Non-infectious, Intermediate-, Posterior- or Pan-uveitis

Active, not recruiting
2
96
Europe, US, RoW
Izokibep, Placebo
ACELYRIN Inc.
Uveitis
08/25
08/25

Download Options